HomeNATCOPHARM • NSE
add
Natco Pharma Ltd.
Nakaraang pagsara
₹1,382.90
Sakop ng araw
₹1,385.85 - ₹1,423.00
Sakop ng taon
₹724.20 - ₹1,639.00
Market cap
253.44B INR
Average na Volume
947.94K
P/E ratio
15.49
Dividend yield
0.39%
Primary exchange
NSE
Mga balita tungkol sa merkado
TipRanks
6 oras ang nakalipas
China Discourages Local Companies from Buying Nvidia (NASDAQ:NVDA) Chips
2.17%
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 13.63B | 19.47% |
Gastos sa pagpapatakbo | 4.22B | 3.11% |
Net na kita | 6.68B | 59.05% |
Net profit margin | 49.06 | 33.13% |
Kita sa bawat share | 37.32 | 60.45% |
EBITDA | 8.07B | 40.06% |
Aktuwal na % ng binabayarang buwis | 16.81% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 18.49B | 59.13% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 58.53B | — |
Natitirang share | 179.13M | — |
Presyo para makapag-book | 4.23 | — |
Return on assets | — | — |
Return on capital | 30.55% | — |
Cash Flow
Net change in cash
| (INR) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 6.68B | 59.05% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and Agro chemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs. The company specialises in producing complex medicines at affordable prices. NATCO is a science driven company and focuses on limited competition molecules in the US. Wikipedia
Itinatag
1981
Headquarters
Website
Mga Empleyado
4,016
